Investment Rating - The investment rating for China Feihe (06186.HK) is "Outperform" (maintained) [1] Core Insights - The company reported a revenue of 18.11 billion yuan in 2025, a decrease of 12.7% year-on-year, with a net profit of 1.94 billion yuan, down 45.7% year-on-year. The second half of 2025 saw a revenue of 8.96 billion yuan, down 15.9% year-on-year, and a net profit of 940 million yuan, down 44.6% year-on-year. The company expects a cumulative dividend payout ratio of 103% for 2025, corresponding to a dividend yield of 7.2% [3][4][6] Summary by Sections Financial Performance - In 2025, the company achieved a revenue of 181.1 billion yuan, a decline of 12.7% year-on-year, and a net profit of 19.4 billion yuan, down 45.7% year-on-year. The second half of 2025 recorded a revenue of 89.6 billion yuan, a decrease of 15.9% year-on-year, and a net profit of 9.4 billion yuan, down 44.6% year-on-year [3][4][6] - The gross margin for the second half of 2025 was 68.3%, an increase of 3.6 percentage points year-on-year, while the net profit margin was 10.5%, a decrease of 5.4 percentage points year-on-year [5] Revenue and Growth Drivers - The company is actively adjusting its main business to stabilize operations and is accelerating the growth of its second curve business. The revenue from infant formula and other dairy products in 2025 was 158.6 billion yuan, down 16.8% year-on-year, while nutritional supplements saw a revenue increase of 6.0% year-on-year [4] - The company launched upgraded products and new series, which are expected to contribute positively to revenue recovery in 2026, alongside the effects of fertility subsidies [4] Valuation Metrics - The estimated earnings per share (EPS) for 2026, 2027, and 2028 are projected to be 0.28, 0.29, and 0.30 yuan, respectively. The current stock price corresponds to a price-to-earnings (P/E) ratio of 9.7, 9.3, and 9.1 for the years 2026, 2027, and 2028 [3][6]

Investment Rating - The investment rating for the company is maintained as "Accumulate" with a target price of RMB 8.16 [6][4]. Core Views - The company reported a revenue of RMB 239.0 million and a net profit attributable to shareholders of -RMB 1.5 million for the year 2025, marking a year-on-year decline of 1.6% and a shift to a loss [1]. - The company's liquid milk and dairy farming products faced operational pressure due to external environmental factors and the raw milk cycle being at a low point, although other dairy product revenues showed positive growth [1]. - The company is committed to its "fresh strategy" and is continuing to promote the national layout of low-temperature milk [1]. Revenue Breakdown - In 2025, revenue from liquid milk, other dairy products, and farming products was RMB 132.2 million, RMB 84.7 million, and RMB 9.1 million respectively, with year-on-year changes of -6.7%, +8.7%, and -11.2% [2]. - The fourth quarter of 2025 saw revenues of RMB 30.8 million from liquid milk, RMB 23.0 million from other dairy products, and RMB 2.0 million from farming products, with year-on-year changes of +0.3%, +5.5%, and -6.2% respectively [2]. Profitability Metrics - The gross margin for 2025 decreased by 2.0 percentage points to 17.3%, while the net profit margin attributable to shareholders fell by 3.6 percentage points to -0.6% [3]. - The company faced significant losses due to operational issues at its subsidiary, resulting in a negative net profit for the year [3]. Earnings Forecast and Valuation - Revenue forecasts for 2026 and 2027 have been adjusted downwards to RMB 243.1 million and RMB 253.0 million, reflecting a decrease of 5% from previous estimates [4]. - The expected net profit attributable to shareholders for 2026 and 2027 is RMB 4.8 million and RMB 6.6 million, respectively, which is a reduction of 27% and 7% from prior forecasts [4]. - The estimated earnings per share (EPS) for 2026, 2027, and 2028 are projected to be RMB 0.35, RMB 0.48, and RMB 0.52 respectively [4].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司行业信息披露指引第十四号——食品制造》 的相关规定，现将光明乳业股份有限公司 2025 年度主要经营数据公告如下： 一、主营业务按产品类别分类情况 单位：元 币种：人民币 证券代码：600597 证券简称：光明乳业 公告编号：临 2026-012 号 光明乳业股份有限公司 关于 2025 年度经营数据的公告 | 产品 | 2025 年 | 1-12 | 月 | 2024 年 | 1-12 | 月 | 同比变动（%） | | --- | --- | --- | --- | --- | --- | --- | --- | | 液态奶 | | 13,223,143,776 | | 14,165,789,486 | | | -6.65 | | 其他乳制品 | | 8,466,119,024 | | 7,790,749,398 | | | 8.67 | | 牧业产品 | | | 909,328,777 | 1,023,457,726 | | | -11.15 | ...

证券代码：600597 证券简称：光明乳业 公告编号：临 2025-033 号 光明乳业股份有限公司 关于 2025 年第三季度经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 单位：元 币种：人民币 产品 2025 年 1-9 月 2024 年 1-9 月 同比变动（%） 液态奶 10,145,714,593 11,096,794,173 -8.57 其他乳制品 6,170,452,257 5,613,990,017 9.91 牧业产品 706,786,276 807,639,741 -12.49 其他 1,079,355,693 838,526,919 28.72 单位：元 币种：人民币 地区 2025 年 1-9 月 2024 年 1-9 月 同比变动（%） 上海 5,199,308,114 5,416,078,817 -4.00 外地 7,392,062,271 7,668,028,634 -3.60 境外 5,510,938,434 5,272,843,399 4.52 单位：元 币种：人民币 销售模式 ...

Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, with a focus on the challenges faced in the liquid milk and livestock product segments, while other dairy products showed positive growth [1][2]. Revenue Summary - For 25H1, the revenue from liquid milk, other dairy products, and livestock products was 66.1 billion, 44.5 billion, and 5.2 billion respectively, showing year-on-year changes of -8.6%, +8.8%, and -13.8% [2]. - In 25Q2, the revenue for liquid milk, other dairy products, and livestock products was -10.8%, +6.1%, and +140.4% year-on-year, indicating a mixed performance across product lines [2]. - Regional performance in 25H1 showed revenue from Shanghai, other regions, and overseas at 34.9 billion, 49.9 billion, and 39.4 billion respectively, with year-on-year changes of -6.9%, -1.5%, and +1.9% [2]. - Channel-wise, direct sales, distributors, and other channels generated revenues of 27.6 billion, 95.7 billion, and 0.8 billion respectively, with year-on-year changes of -1.1%, -2.2%, and -13.1% [2]. Profitability Summary - The gross margin for 25H1 decreased by 1.0 percentage points to 18.9%, while the net profit margin and the non-recurring net profit margin were 1.7% and 2.0% respectively, both showing declines [3]. - The sales expense ratio for 25H1 decreased by 0.8 percentage points to 10.9%, indicating effective cost control [3]. - The management expense ratio also saw a decline, down by 0.4 percentage points to 3.3% in 25H1 [3]. Outlook and Valuation - The company anticipates a gradual recovery in overall dairy product demand, benefiting from a balanced supply-demand situation in the raw milk cycle starting in 2026 [4]. - The earnings per share (EPS) forecast for 2025-2027 is adjusted to 0.45, 0.48, and 0.52 yuan, reflecting slight changes from previous estimates [4]. - The target price is set at 9.90 yuan based on a price-to-earnings (PE) ratio of 22x for 2025, indicating a positive outlook for the company's stock [4].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司行业信息披露指引第十四号——食品制造》 的相关规定，现将光明乳业股份有限公司 2025 年半年主要经营数据（未经审计） 公告如下： 一、主营业务按产品类别分类情况 二、主营业务按地区分类情况 单位：元 币种：人民币 证券代码：600597 证券简称：光明乳业 公告编号：临 2025-027 号 光明乳业股份有限公司 关于 2025 年半年度经营数据的公告 三、主营业务按销售模式分类情况 1 单位：元 币种：人民币 产品 2025 年 1-6 月 2024 年 1-6 月 同比变动（%） 液态奶 6,605,665,104 7,230,518,115 -8.64 其他乳制品 4,450,205,636 4,091,971,145 8.75 牧业产品 517,514,528 600,069,430 -13.76 其他 835,639,498 749,169,847 11.54 单位：元 币种：人民币 销售模式 2025 年 1-6 月 2024 年 1-6 ...

Core Viewpoint - The dairy industry faced significant challenges in the past year, but Bright Dairy has managed to achieve its profit targets despite a decline in liquid milk revenue and overall market pressures [1][4]. Financial Performance - Bright Dairy reported a total revenue of 24.28 billion yuan and a net profit attributable to shareholders of 722 million yuan for the year 2024, meeting its profit goals [1]. - Revenue from liquid milk decreased by 9.47% year-on-year to 14.166 billion yuan, while other dairy products saw a 5.87% increase to 7.791 billion yuan [1]. - The company generated approximately 2.2 billion yuan from its livestock and other segments [1]. - Internationally, revenue from the investment in New Zealand's Newlite contributed 7.439 billion yuan, accounting for over 30% of total revenue [1]. Market Outlook - The chairman of Bright Dairy, Huang Liming, described the current dairy market as having both challenges and opportunities, with short-term impacts from raw milk price fluctuations and changing market demands [4]. - The company anticipates a total revenue target of 26.196 billion yuan and a net profit of 339 million yuan for the current year, aiming for a return on equity greater than 3.48% [4]. Strategic Initiatives - Bright Dairy plans to enhance profitability through various strategies across its operations, including improving milk production quality, optimizing production capacity, and leveraging technology in logistics [4]. - The company aims to maintain its market share in fresh milk, expand into instant retail channels, and explore the tea beverage raw milk market [4]. - In response to weak consumer demand, Bright Dairy is focusing on partnerships with B2B sectors, particularly in the restaurant and tea beverage industries, exemplified by its collaboration with MANNER Coffee [4][5]. Growth Plans - The management highlighted plans to continue promoting key products like Bright Youbei and Rushi, while also customizing dairy products for specific channels such as fresh tea drinks and baked goods [5]. - The company intends to penetrate the instant retail market and enhance the quality of traditional distribution channels to improve overall operational efficiency [5].

Investment Rating - The report maintains an "Accumulate" rating for the company [6]. Core Views - The company reported a total revenue of 24.28 billion yuan for 2024, a decrease of 8.33% year-on-year, with a net profit attributable to shareholders of 722 million yuan, down 25.36% year-on-year [1][4]. - The fourth quarter of 2024 showed a slight revenue increase of 0.75% year-on-year, with a net profit of 606 million yuan, a decrease of 6.04% year-on-year [1]. - The first quarter of 2025 saw a revenue of 6.37 billion yuan, a decrease of 0.76% year-on-year, while the net profit attributable to shareholders was 141 million yuan, down 18.16% year-on-year [1][2]. Revenue and Profit Analysis - In Q1 2025, the revenue from liquid milk, other dairy products, and livestock products was 3.29 billion, 2.42 billion, and 211 million yuan respectively, with year-on-year changes of -6.32%, +11.10%, and -55.40% [2]. - The company's gross margin for 2024 was 19.23%, with a slight decline in Q1 2025 to 18.66% [3][13]. - The net profit margin for 2024 was 2.97%, with a significant increase in Q4 2024 due to land compensation income [3]. Forecast and Valuation - The profit forecast for 2025 and 2026 has been revised down to 556 million and 626 million yuan respectively, with a new forecast for 2027 at 707 million yuan [4][5]. - The estimated EPS for 2025, 2026, and 2027 is projected to be 0.40, 0.45, and 0.51 yuan respectively, with corresponding P/E ratios of 20, 18, and 16 times [4][5].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 9.00, up from the previous target of RMB 8.41 [4][7]. Core Views - The company is expected to see improvements in revenue and profit margins as it continues to implement its "Fresh Strategy" and expand its low-temperature milk distribution nationwide [1][4]. - The company faced challenges in 2024, with a decline in revenue and net profit, but there are signs of recovery in early 2025 [1][4]. Revenue and Profit Analysis - In 2024, the company achieved revenue of RMB 24.28 billion, a decrease of 8.3% year-on-year, with a net profit attributable to the parent company of RMB 720 million, down 25.4% [1][6]. - The fourth quarter of 2024 saw a slight revenue increase of 0.8% year-on-year, but net profit decreased by 6.0% [1]. - For Q1 2025, revenue was RMB 6.37 billion, a slight decrease of 0.8% year-on-year, while net profit attributable to the parent company decreased by 18.2% [1][6]. Product and Regional Performance - In 2024, revenue from liquid milk, other dairy products, and livestock was RMB 14.17 billion, RMB 7.79 billion, and RMB 1.02 billion, respectively, with liquid milk revenue declining by 9.5% [2]. - The Shanghai region showed stable performance, while overseas revenue continued to expand [2]. Margin and Cost Management - The gross margin for 2024 was 19.2%, down 0.4 percentage points year-on-year, while the net profit margin attributable to the parent company was 3.0% [3]. - In Q1 2025, the gross margin decreased to 18.7%, but the net profit margin improved slightly to 2.2% [3]. Future Outlook - The company anticipates a gradual recovery in consumer demand and expects to reduce losses from culling cows in 2025 [4]. - The earnings per share (EPS) forecast for 2025 and 2026 has been raised to RMB 0.45 and RMB 0.48, respectively [4].

单位：元 币种：人民币 产品 2025 年 1-3 月 2024 年 1-3 月 同比变动（%） 液态奶 3,291,885,260 3,514,037,078 -6.32 其他乳制品 2,414,550,844 2,173,355,713 11.10 牧业产品 210,720,723 472,430,460 -55.40 其他 430,441,905 245,159,668 75.58 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司行业信息披露指引第十四号——食品制造》 的相关规定，现将光明乳业股份有限公司 2025 年第一季度主要经营数据（未经 审计）公告如下： 一、主营业务按产品类别分类情况 注：1、牧业产品收入降低主要原因是受市场行情影响，饲料业务收入下降。 2、其他产品收入增加主要原因是随心订第三方产品销售收入增加。 二、主营业务按地区分类情况 三、主营业务按销售模式分类情况 1 证券代码：600597 证券简称：光明乳业 公告编号：临 2025-008 号 光明乳业股份有限公司 关于 ...